Cell Based Assays

Optimised assays for data integrity and throughput.

hLAB provides a broad portfolio of serological and infectivity assays for a range of target pathogens. All our assays are optimised for both data integrity and throughput. hLAB process and analysis:

Serological Assays:
  • Determination of antibody titres, Coronavirus alpha and beta (OC43, 229E, SARS-CoV2), RSV A & B and FLU (H3N2 & H1N1) viruses, bespoke target virus and proteins
  • Hemagglutination inhibition assays, Foci reduction neutralisation assays (FRNA), Plaque reduction neutralisation tests (PRNT), microneutralisation assay (MNA), ELISA for IgG, IgM & IgA
Infectivity Assays:
  • Identification and quantification of infections virus present in samples
  • Plaque forming or 50% tissue culture infectious dose (TCID50) assay
Optimised for high throughput and validity of results.

If you’re a potential customer, job seeker, health professional or an investor, find out how we can help you.

Contact hVIVO

Stay connected

Sign up to our emails and follow us on social media to keep up to date with hVIVO.

By clicking Sign Up you're confirming that you agree with our Privacy Policy.
chevron-downarrow-up